{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:32:31Z","timestamp":1786789951263,"version":"build-2736575974"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jaut.2018.10.007","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:45:53Z","timestamp":1539996353000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Juvenile autoimmune hepatitis: A comprehensive review"],"prefix":"10.1016","volume":"95","author":[{"given":"Christiane","family":"Sokollik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie A.","family":"McLin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Terziroli Beretta-Piccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2018.10.007_bib1","article-title":"Diagnosis and management of paediatric autoimmune liver disease: ESPGHAN Hepatology committee position statement","author":"Mieli-Vergani","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib2","doi-asserted-by":"crossref","first-page":"e1237","DOI":"10.1542\/peds.2015-0578","article-title":"Incidence and characteristics of autoimmune hepatitis","volume":"136","author":"Jim\u00e9nez-Rivera","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaut.2018.10.007_bib3","series-title":"Autoimmune Dis","first-page":"889","article-title":"Chapter 61 - hepatitis","author":"Vergani","year":"2014"},{"key":"10.1016\/j.jaut.2018.10.007_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2002-35705","article-title":"Genetics in autoimmune hepatitis","volume":"22","author":"Donaldson","year":"2002","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jaut.2018.10.007_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/gut.2003.031732","article-title":"Genetics of liver disease: immunogenetics and disease pathogenesis","volume":"53","author":"Donaldson","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2018.10.007_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/gene.2014.82","article-title":"Dutch Autoimmune Hepatitis Study Group, HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1","volume":"16","author":"van Gerven","year":"2015","journal-title":"Gene Immun."},{"key":"10.1016\/j.jaut.2018.10.007_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12876-015-0360-9","article-title":"Evaluation of the role of HLA-DR antigens in Japanese type 1 autoimmune hepatitis","volume":"15","author":"Furumoto","year":"2015","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.007_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Dutch autoimmune hepatitis study group, lifelines cohort study, study of health in pomerania, genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.007_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.jaut.2018.10.007_bib10","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/j.1572-0241.1998.1394a.x","article-title":"Different HLA profiles confer susceptibility to autoimmune hepatitis type 1 and 2","volume":"93","author":"Bittencourt","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.007_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1824-7288-36-73","article-title":"HLA-DRB1 as a risk factor in children with autoimmune hepatitis and its relation to hepatitis A infection","volume":"36","author":"Elfaramawy","year":"2010","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.jaut.2018.10.007_bib12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jhep.2004.02.023","article-title":"Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients","volume":"40","author":"Djilali-Saiah","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.007_bib13","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.007_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.autrev.2010.09.024","article-title":"Autoimmune hepatitis, HLA and extended haplotypes","volume":"10","author":"Oliveira","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.10.007_bib15","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.510300611","article-title":"Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition","volume":"30","author":"Pando","year":"1999","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jaut.2018.10.007_bib16","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1053\/jhep.2001.24562","article-title":"Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis","volume":"33","author":"Fainboim","year":"2001","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.jaut.2018.10.007_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(85)90348-4","article-title":"Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis","volume":"2","author":"Vergani","year":"1985","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.jaut.2018.10.007_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/bmb\/ldh032","article-title":"Genetic insights into disease mechanisms of autoimmunity","volume":"71","author":"Simmonds","year":"2004","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.jaut.2018.10.007_bib19","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJM199006283222601","article-title":"Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients","volume":"322","author":"Ahonen","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2018.10.007_bib20","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/jc.2011-2461","article-title":"Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients","volume":"97","author":"Meloni","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2018.10.007_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2018.05.035","article-title":"Family occurrence of autoimmune hepatitis: a Danish nationwide registry-based cohort study","author":"Gr\u00f8nb\u00e6k","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.007_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MPG.0000000000000995","article-title":"Environmental risk factors of pediatric-onset primary sclerosing cholangitis and autoimmune hepatitis","volume":"62","author":"Tenca","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MPG.0000000000000245","article-title":"Autoantibody and human leukocyte antigen profiles in children with autoimmune liver disease and their first-degree relatives","volume":"58","author":"Wang","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bpg.2011.09.009","article-title":"Pathogenesis of autoimmune hepatitis","volume":"25","author":"Liberal","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.007_bib25","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase","volume":"88","author":"Manns","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.007_bib26","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.21658","article-title":"Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2","volume":"46","author":"Longhi","year":"2007","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jaut.2018.10.007_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.007_bib28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.22071","article-title":"Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis","volume":"47","author":"Longhi","year":"2008","journal-title":"Hepatol. Baltim. Md"},{"issue":"2006","key":"10.1016\/j.jaut.2018.10.007_bib29","first-page":"4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"1950","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.jaut.2018.10.007_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.10.007_bib31","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.25682","article-title":"The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9\/tim-3 pathway","volume":"56","author":"Liberal","year":"2012","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jaut.2018.10.007_bib32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.26583","article-title":"Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis","volume":"59","author":"Grant","year":"2014","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.jaut.2018.10.007_bib33","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.27884","article-title":"In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression","volume":"62","author":"Liberal","year":"2015","journal-title":"Hepatol. Baltim. Md"},{"issue":"2003","key":"10.1016\/j.jaut.2018.10.007_bib34","first-page":"1481","article-title":"Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease","volume":"170","author":"Kerkar","year":"1950","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.jaut.2018.10.007_bib35","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0140-6736(05)62476-2","article-title":"Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance","volume":"350","author":"Vento","year":"1997","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.jaut.2018.10.007_bib36","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/hep.27998","article-title":"A novel \u201chumanized mouse\u201d model for autoimmune hepatitis and the association of gut microbiota with liver inflammation","volume":"62","author":"Yuksel","year":"2015","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jaut.2018.10.007_bib37","first-page":"5153","article-title":"Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis","volume":"8","author":"Lin","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jaut.2018.10.007_bib38","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.jaut.2018.10.007_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2018.07.006","article-title":"Autoimmune liver disease serology in acute hepatitis E virus infection","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.10.007_bib40","first-page":"449","article-title":"Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long-term outcomes","volume":"37","author":"Wong","year":"2017","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"issue":"Suppl 2","key":"10.1016\/j.jaut.2018.10.007_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000440707","article-title":"Association of extrahepatic manifestations with autoimmune hepatitis","volume":"33","author":"Wong","year":"2015","journal-title":"Dig. Dis. Basel Switz."},{"key":"10.1016\/j.jaut.2018.10.007_bib42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","article-title":"Autoimmune hepatitis: a comprehensive review","volume":"41","author":"Liberal","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.10.007_bib43","article-title":"Serology in autoimmune hepatitis: a clinical-practice approach","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jaut.2018.10.007_bib44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.clinre.2014.02.010","article-title":"A practical approach to the child with abnormal liver tests","volume":"38","author":"Lamireau","year":"2014","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.007_bib45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Zum B\u00fcschenfelde, Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.jaut.2018.10.007_bib46","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","author":"Ma","year":"2002","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jaut.2018.10.007_bib47","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/0891693021000056712","article-title":"Anti-soluble liver antigen\/liver-pancreas (SLA\/LP) antibodies in pediatric patients with autoimmune hepatitis","volume":"35","author":"Vitozzi","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2018.10.007_bib48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2249.2000.01280.x","article-title":"Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis","volume":"121","author":"Costa","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.10.007_bib49","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.jaut.2018.10.007_bib50","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/0891693021000056721","article-title":"Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease","volume":"35","author":"Gregorio","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2018.10.007_bib51","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.26666","article-title":"Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis","volume":"59","author":"Couto","year":"2014","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jaut.2018.10.007_bib52","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","article-title":"Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis","volume":"42","author":"Muratori","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2018.10.007_bib53","first-page":"785","article-title":"Seronegative autoimmune hepatitis in children: spectrum of disorders","volume":"48","author":"Maggiore","year":"2016","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"10.1016\/j.jaut.2018.10.007_bib54","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"International autoimmune hepatitis group, liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group","volume":"41","author":"Vergani","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.007_bib55","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/his.12558","article-title":"Assessment of the histopathological key features in autoimmune hepatitis","volume":"66","author":"de Boer","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.jaut.2018.10.007_bib56","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.1840030510","article-title":"Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis","volume":"3","author":"Hegarty","year":"1983","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jaut.2018.10.007_bib57","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: international autoimmune hepatitis group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jaut.2018.10.007_bib58","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.007_bib59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"International autoimmune hepatitis group, simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jaut.2018.10.007_bib60","first-page":"935","article-title":"Diagnosing autoimmune hepatitis in children: is the International Autoimmune Hepatitis Group scoring system useful?","volume":"2","author":"Ebbeson","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.jaut.2018.10.007_bib61","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.3748\/wjg.v18.i33.4470","article-title":"Diagnostic criteria for autoimmune hepatitis in children: a challenge for pediatric hepatologists","volume":"18","author":"Ferri","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.007_bib62","first-page":"417","article-title":"Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children","volume":"10","author":"Mileti","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.jaut.2018.10.007_bib63","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/MPG.0b013e3181fc1e0b","article-title":"Utility of simplified criteria for the diagnosis of autoimmune hepatitis in children","volume":"52","author":"Hiejima","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib64","first-page":"302","article-title":"Autoimmune hepatitis in children: experiences in a tertiary center, Iran","volume":"23","author":"Dehghani","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jaut.2018.10.007_bib65","first-page":"36","article-title":"Autoimmune hepatitis in India: single tertiary referral centre experience","volume":"36","author":"Amarapurkar","year":"2015","journal-title":"Trop. Gastroenterol. Off. J. Dig. Dis. Found."},{"key":"10.1016\/j.jaut.2018.10.007_bib66","first-page":"178","article-title":"Clinico-laboratory study on children with auto-immune hepatitis in Upper Egypt","volume":"12","author":"Abu Faddan","year":"2011","journal-title":"Arab. J. Gastroenterol. Off. Publ. Pan-Arab Assoc. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.007_bib67","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MPG.0b013e3181a1c265","volume":"49","author":"Mieli-Vergani","year":"2009","journal-title":"Autoimmune Hepat., J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib68","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/01.mpg.0000304456.84552.13","article-title":"Effect of treatment of hepatic histopathology in children and adolescents with autoimmune hepatitis","volume":"46","author":"Ferreira","year":"2008","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.hepres.2005.12.002","article-title":"Intravenous methylprednisolone pulse therapy for children with autoimmune hepatitis","volume":"34","author":"Sogo","year":"2006","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jaut.2018.10.007_bib70","doi-asserted-by":"crossref","DOI":"10.1097\/MPG.0000000000001563","article-title":"Outcomes in pediatric autoimmune hepatitis and significance of azathioprine metabolites","author":"Sheiko","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib71","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.3748\/wjg.v23.i33.6030","article-title":"Autoimmune hepatitis: standard treatment and systematic review of alternative treatments","volume":"23","author":"Beretta-Piccoli","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.007_bib72","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"European association for the study of the liver, EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.007_bib73","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4245","article-title":"Two cases of hepatosplenic T-cell lymphoma in adolescents treated for autoimmune hepatitis","volume":"138","author":"Brinkert","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaut.2018.10.007_bib74","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.mpg.0000232331.93052.dd","article-title":"Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis","volume":"43","author":"Banerjee","year":"2006","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib75","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jpeds.2013.05.042","article-title":"European Autoimmune Hepatitis-Budesonide Study Group, Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents","volume":"163","author":"Woynarowski","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jaut.2018.10.007_bib76","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jpeds.2013.06.064","article-title":"Budesonide for juvenile autoimmune hepatitis? Not yet","volume":"163","author":"Mieli-Vergani","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jaut.2018.10.007_bib77","doi-asserted-by":"crossref","DOI":"10.1097\/MPG.0000000000001530","article-title":"Second-line agents in pediatric patients with autoimmune hepatitis: a systematic review and meta-analysis","author":"Zizzo","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib78","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s10620-018-5011-x","article-title":"Tacrolimus and mycophenolate mofetil as second-line therapies for pediatric patients with autoimmune hepatitis","volume":"63","author":"Efe","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2018.10.007_bib79","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1542\/peds.2011-1900","article-title":"Successful treatment of refractory autoimmune hepatitis with rituximab","volume":"132","author":"D'Agostino","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaut.2018.10.007_bib80","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jpeds.2012.11.038","article-title":"Leveraging administrative data to monitor rituximab use in 2875 patients at 42 freestanding children's hospitals across the United States","volume":"162","author":"Kavcic","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jaut.2018.10.007_bib81","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2013.05.046","article-title":"Infliximab as rescue therapy in paediatric autoimmune hepatitis","volume":"59","author":"Rajanayagam","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.007_bib82","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/MPG.0000000000001759","article-title":"anti-tnf\u03b1 treatment in children and adolescents with combined inflammatory bowel disease and autoimmune liver disease","volume":"66","author":"Nedelkopoulou","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib83","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.007_bib84","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/MPG.0000000000001137","article-title":"Infliximab-associated immunomediated hepatitis in children with inflammatory bowel disease","volume":"63","author":"Mostamand","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib85","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","article-title":"Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells","volume":"105","author":"Battaglia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2018.10.007_bib86","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1097\/MPG.0b013e318291feaa","article-title":"Sirolimus as rescue therapy in pediatric autoimmune hepatitis","volume":"58","author":"Kurowski","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib87","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.26454","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history","volume":"58","author":"Deneau","year":"2013","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.jaut.2018.10.007_bib88","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12072-014-9558-0","article-title":"Characteristics and outcome of autoimmune liver disease in Asian children","volume":"9","author":"Lee","year":"2015","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jaut.2018.10.007_bib89","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/01.mpg.0000239735.87111.ba","article-title":"Prospective analysis of nonadherence in autoimmune hepatitis: a common problem","volume":"43","author":"Kerkar","year":"2006","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib90","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jaut.2018.10.007_bib91","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence","volume":"52","author":"Duclos-Vall\u00e9e","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2018.10.007_bib92","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MPG.0b013e3181bf0ef7","article-title":"Childhood autoimmune liver disease: indications and outcome of liver transplantation","volume":"50","author":"Chai","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib93","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14218\/JCTH.2014.00032","article-title":"Update on autoimmune hepatitis","volume":"3","author":"Liberal","year":"2015","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.007_bib94","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1097\/MPG.0000000000001438","article-title":"Liver transplantation for children with primary sclerosing cholangitis and autoimmune hepatitis: UNOS database analysis","volume":"64","author":"Jossen","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.007_bib95","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Autoimmune Hepat. Nat. Rev. Dis. Primer."},{"key":"10.1016\/j.jaut.2018.10.007_bib96","doi-asserted-by":"crossref","first-page":"e1237","DOI":"10.1542\/peds.2015-0578","article-title":"Incidence and characteristics of autoimmune hepatitis","volume":"136","author":"Jim\u00e9nez-Rivera","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaut.2018.10.007_bib97","first-page":"1562","article-title":"Canadian Paediatric Hepatology Research Group (CPHRG), A national retrospective study of paediatric end-stage liver disease as a predictor of change to second-line therapy in children with autoimmune hepatitis","volume":"37","author":"Zizzo","year":"2017","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.jaut.2018.10.007_bib98","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41598-017-18818-5","article-title":"Baseline IL-2 and the AIH score can predict the response to standard therapy in paediatric autoimmune hepatitis","volume":"8","author":"Diestelhorst","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2018.10.007_bib99","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.007_bib100","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpg.2011.10.007","article-title":"Autoimmune liver diseases in children - what is different from adulthood?","volume":"25","author":"Mieli-Vergani","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.007_bib101","article-title":"Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression","volume":"6","author":"Zhao","year":"2011","journal-title":"PloS One"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118305791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118305791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:21:33Z","timestamp":1760257293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841118305791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":101,"alternative-id":["S0896841118305791"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2018.10.007","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile autoimmune hepatitis: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2018.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}